How is anemia classified according to severity?

Classification of Anemia According to Severity

Anemia is classified into three severity levels: mild (Hb 10-11.9 g/dL), moderate (Hb 8-9.9 g/dL), and severe (Hb <8 g/dL) according to the most recent guidelines. 1

Standard Classification System

The classification of anemia severity follows a well-established framework:

• Mild anemia: Hemoglobin 10-11.9 g/dL
• Moderate anemia: Hemoglobin 8-9.9 g/dL
• Severe anemia: Hemoglobin <8 g/dL

This classification system is consistently supported by multiple guidelines, including those from the European Society for Medical Oncology (ESMO) 2 and is reflected in the most recent clinical practice summaries 1.

Treatment-Related Anemia Grading

For treatment-related anemia, particularly in cancer patients, the National Cancer Institute's Common Toxicity Criteria of Adverse Events (CTCAE v3) provides a more detailed grading system:

• Grade 0: Hemoglobin within normal limits
• Grade 1: Hemoglobin from lower normal limit to 10.0 g/dL
• Grade 2: Hemoglobin 8.0 to <10.0 g/dL
• Grade 3: Hemoglobin 6.5 to <8.0 g/dL
• Grade 4: Hemoglobin <6.5 g/dL
• Grade 5: Death

2, 1

Clinical Implications of Anemia Severity

The severity classification has important clinical implications:

• Mild anemia (10-11.9 g/dL): Often asymptomatic but may cause fatigue and reduced exercise tolerance. In cancer patients, mild anemia affects approximately 30-39% of patients 1.

• Moderate anemia (8-9.9 g/dL): More likely to cause symptoms including fatigue, dyspnea, and reduced quality of life. Affects about 9-14% of cancer patients 1.

• Severe anemia (<8 g/dL): Associated with significant symptoms, increased morbidity and mortality, and may require more urgent intervention including blood transfusion. Affects approximately 1% of cancer patients 1.

Prevalence and Impact

Anemia has significant impacts on patient outcomes:

• Negatively affects quality of life and is a major factor in cancer-related fatigue 2, 1
• Constitutes a negative prognostic factor for overall survival in most cancer types 2, 1
• Associated with increased morbidity, mortality, decreased work productivity, and impaired neurological development 3
• In elderly populations, even mild anemia is associated with increased risk for mortality, cardiovascular disease, cognitive dysfunction, falls, and fractures 4

Important Considerations

When evaluating anemia, it's important to note:

• The WHO defines anemia as hemoglobin <13 g/dL in men and <12 g/dL in women 5, but the severity classification remains consistent across genders
• Normal hemoglobin distribution varies with sex, ethnicity, and physiological status 5
• Anemia is often multifactorial and should be evaluated in context of the underlying cause 6
• In elderly populations, some experts have proposed adjusted definitions, with levels <12 g/dL considered anemic in both sexes 5, 4

Diagnostic Approach

When anemia is identified, a systematic approach should be taken:

• Complete blood count with reticulocyte count
• Iron studies (ferritin, transferrin saturation)
• Vitamin B12 and folate levels
• Assessment for occult blood loss
• Evaluation of renal function
• Peripheral blood smear examination

1

This comprehensive evaluation helps identify the underlying cause, which is essential for appropriate management of anemia regardless of its severity.